{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T19:27:24Z","timestamp":1768073244749,"version":"3.49.0"},"reference-count":46,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background: Age, genetic, and environmental factors are noted to contribute to dementia risk. Neuroplasticity, protection from degeneration and cell death, and early intervention are desirable for preventing dementia. The linkage between neurons and microglia has been a research focus. In this study, we examined the effects of dietary modification (a reduction in advanced glycation end products [AGEs]) and macrophage-activating factor (MAF; a macrophage regulator) supplementation on cognitive function in elderly participants undergoing rehabilitation. Methods: Participants were older than 60 years of age and had been attending a daycare rehabilitation facility for at least three months without cognitive dysfunction, severe anemia, terminal cancer, or neurodegenerative diseases such as Parkinson\u2019s disease. The exercise protocol at the rehabilitation facility was not changed during the study period. Forty-three participates were randomly divided into three groups: a control group receiving placebo, a group receiving dietary guidance, and a group receiving dietary guidance and MAF supplementation. The amyloid-\u03b240\/42 ratio, dietary AGE intake, plasma AGE levels, dietary caloric intake, and mild cognitive impairment (MCI) screen test were evaluated. Results: Four participants withdrew from the study. MCI screening scores significantly improved in the MAF supplementation group, especially after 6 months. Dietary modulation was also more effective than placebo at improving cognitive function after 12 months. Only the control group exhibited significantly increased plasma AGEs while the dietary modulation and MAF supplementation groups showed no change in plasma AGEs after 12 months. Conclusions: MAF supplementation improved cognitive function, especially after 6 months, in elderly people undergoing rehabilitation. Dietary modulation was also effective for improving cognitive function after 12 months compared to that in the control group. It was difficult to supervise meals during dietary guidance at the daycare service. However, simple guidance could show improvements in cognitive function through diet.<\/jats:p>","DOI":"10.3390\/nu16132078","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T04:53:27Z","timestamp":1719809607000},"page":"2078","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Effects of Dietary Intervention and Macrophage-Activating Factor Supplementation on Cognitive Function in Elderly Users of Outpatient Rehabilitation"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-9614","authenticated-orcid":false,"given":"Yoko","family":"Uchiyama-Tanaka","sequence":"first","affiliation":[{"name":"Yoko Clinic, 3-3-13 Takami, Yahatahigashiku, Kitakyushu 805-0016, Fukuoka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"Yamakage","sequence":"additional","affiliation":[{"name":"Satista Co., Ltd., 77-1, Minamiochiai, Makishimama-cho, Uji 611-0041, Kyoto, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Inui","sequence":"additional","affiliation":[{"name":"Inui Clinic, 3-34, 8-2, Okubo-cho, Moriguchi 570-0012, Osaka, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Rao, R.V., Subramaniam, V.K.G., Gregory, J., Bredesen, A., Coward, C., Okada, S., Kelly, L., and Bredesen, D.E. (2023). Rationale for a multi-factorial approach for the reversal of cognitive decline in Alzheimer\u2019s disease and MCI: A review. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021659"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3233\/JAD-215707","article-title":"Precision medicine approach to Alzheimer\u2019s disease: Successful pilot project","volume":"88","author":"Troups","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1055\/a-2015-8041","article-title":"Receptor for advanced glycation end products: Dementia and cognitive impairment","volume":"73","author":"Singh","year":"2023","journal-title":"Drug Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2014.06.008","article-title":"Sublime microglia: Expanding roles for the guardians of the CNS","volume":"158","author":"Salter","year":"2014","journal-title":"Cell"},{"key":"ref_6","unstructured":"GBD 2019 Dementia Forecasting Collaborators (2022). Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: An analysis for the Global Burden of Disease Study 2019. Lancet Public Health, 2, e105\u2013e125."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.18632\/aging.100981","article-title":"Reversal of cognitive decline in Alzheimer\u2019s disease","volume":"8","author":"Bredesen","year":"2016","journal-title":"Aging"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.stem.2019.05.003","article-title":"Human hippocampal neurogenesis persists in aged adults and Alzheimer\u2019s disease patients","volume":"24","author":"Tobin","year":"2019","journal-title":"Cell Stem Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-022-05534-y","article-title":"Microglia regulate central nervous system myelin growth and integrity","volume":"613","author":"McNamara","year":"2023","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1113\/JP272134","article-title":"Microglia across the lifespan: From origin to function in brain development, plasticity and cognition","volume":"595","author":"Tay","year":"2016","journal-title":"J. Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.conb.2015.12.004","article-title":"New insights on the role of microglia in synaptic pruning in health and disease","volume":"36","author":"Hong","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1017\/S1740925X12000014","article-title":"Microglia and neuronal cell death","volume":"7","author":"Cuadros","year":"2011","journal-title":"Neuron Glia Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.stem.2010.08.014","article-title":"Microglia shape adult hippocampal neurogenesis through apoptosis-coupled phagocytosis","volume":"7","author":"Sierra","year":"2010","journal-title":"Cell Stem Cell"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00401-021-02372-6","article-title":"Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u2019s pathology","volume":"143","author":"Smith","year":"2022","journal-title":"Acta Neuropathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","article-title":"Astrocyte and macrophage regulatio of YKL-40 expression and cellular response in neuroinflammation","volume":"22","author":"Bissel","year":"2012","journal-title":"Brain Pathol."},{"key":"ref_17","first-page":"3689","article-title":"Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity","volume":"25","author":"Nagasawa","year":"2005","journal-title":"Anticancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.3390\/nu5072577","article-title":"A novel role for a major component of the vitamin D axis: Vitamin D binding protein-derived macrophage activating factor induces human breast cancer cell apoptosis through stimulation of macrophages","volume":"5","author":"Thyer","year":"2013","journal-title":"Nutrients"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.4049\/jimmunol.151.5.2794","article-title":"Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells","volume":"151","author":"Yamamoto","year":"1993","journal-title":"J. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1177\/0271678X221147090","article-title":"Role of post-ischemic phase-dependent modulation of anti-inflammatory M2-type macrophages against rat brain damage","volume":"43","author":"Kurashiki","year":"2023","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"102258","DOI":"10.1016\/j.jchemneu.2023.102258","article-title":"Differences in amyloid-\u03b2 and tau\/p-tau deposition in blood-injected mouse brains using micro-syringe to mimic traumatic brain microhemorrhages","volume":"130","author":"Kagusa","year":"2023","journal-title":"J. Chem. Neuroanat."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1742-2094-11-78","article-title":"The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages","volume":"11","author":"Siniscalco","year":"2014","journal-title":"J. Neuroinflamm."},{"key":"ref_23","first-page":"3771","article-title":"Case report: GcMAF treatment in a patient with multiple sclerosis","volume":"36","author":"Inui","year":"2016","journal-title":"Anticancer Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"B105","DOI":"10.1093\/geronj\/45.4.B105","article-title":"Nonenzymatic glycosylation, the Maillard reaction and the aging process","volume":"45","author":"Monnier","year":"1990","journal-title":"J. Gerontol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2015.03.167","article-title":"Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease","volume":"185","author":"Yamagishi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.2174\/138945011798829456","article-title":"Role of advanced glycation end products (AGEs) in osteoporosis in diabetes","volume":"12","author":"Yamagishi","year":"2011","journal-title":"Curr. Drug Targets"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/rej.2012.1335","article-title":"Potential clinical utility of advanced glycation end product cross-link breakers in age- and diabetes-associated disorders","volume":"15","author":"Yamagishi","year":"2012","journal-title":"Rejuvenation Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.2174\/138161207781757051","article-title":"Food-derived advanced glycation end products (AGEs): A novel therapeutic target for various disorders","volume":"13","author":"Yamagishi","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1177\/0300060517736914","article-title":"Association of advanced glycation end products, evaluated by skin autofluoresecence, with lifestlyle habits in a general Japanese population","volume":"46","author":"Isami","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jada.2010.03.018","article-title":"Advanced glycation end products in foods and a practical guide to their reduction in the diet","volume":"110","author":"Uribarri","year":"2010","journal-title":"J. Am. Diet. Assoc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"276950","DOI":"10.1155\/2014\/276950","article-title":"Antiglycation activity of iridoids and their food sources","volume":"2014","author":"West","year":"2014","journal-title":"Int. J. Food Sci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jalz.2008.11.001","article-title":"Development and validation of the memory performance index: Reducing measurement error in recall tests","volume":"5","author":"Shankle","year":"2009","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/1533317511402316","article-title":"Comparison of the memory performance index with standard neuropsychological measures of cognition","volume":"26","author":"Rafii","year":"2011","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jalz.2011.03.009","article-title":"Assessment of cognition in mild cognitive impairment: A comparative study","volume":"7","author":"Snyder","year":"2011","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1073\/pnas.0501157102","article-title":"Methods to improve the detection of mild cognitive impairment","volume":"102","author":"Shankle","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2007-11309","article-title":"Detecting cognitive impairment in primary care: Performance assessment of three screening instruments","volume":"11","author":"Trenkle","year":"2007","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1533317507312624","article-title":"The Japanese MCI screen for early detection of Alzheimer\u2019s disease and related disorders","volume":"23","author":"Cho","year":"2008","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Dement."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1089\/dia.2011.0034","article-title":"Advanced glycation end products, measured as skin autofluorescence and diabetes complications: A systematic review","volume":"13","author":"Bos","year":"2011","journal-title":"Diabetes. Technol. Ther."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.exger.2008.01.012","article-title":"Glycation associated skin autofluorescence and skin elasticity are related to chronological age and body mass index of healthy subjects","volume":"43","author":"Corstjens","year":"2008","journal-title":"Exp. Gerontol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/bbrc.1996.1308","article-title":"Formation of crossline as a fluorescent advanced glycation end product in vitro and in vivo","volume":"226","author":"Obayashi","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nut.2015.08.001","article-title":"Pathologic role of dietary advanced glycation end products in cardiometabolic disorders, and therapeutic intervention","volume":"32","author":"Yamagishi","year":"2016","journal-title":"Nutrition"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00125-018-4769-x","article-title":"Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population","volume":"62","author":"Fokkens","year":"2019","journal-title":"Diabetologia"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): A randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/jama.2009.1144","article-title":"Physical activity, diet, and risk of Alzheimer disease","volume":"302","author":"Scarmeas","year":"2009","journal-title":"JAMA"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/13\/2078\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:07:26Z","timestamp":1760108846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/16\/13\/2078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,28]]},"references-count":46,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["nu16132078"],"URL":"https:\/\/doi.org\/10.3390\/nu16132078","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,28]]}}}